Byotrol PLC Director/PDMR Shareholding (6423P)
19 Febbraio 2016 - 4:34PM
UK Regulatory
TIDMBYOT
RNS Number : 6423P
Byotrol PLC
19 February 2016
19 February 2016
Byotrol plc
HOLDING IN COMPANY
DIRECTOR/PDMR HOLDING
Byotrol plc ("Byotrol" or the "Company"), the specialist
anti-microbial technology company, was notified on 16 February 2016
that Maunby Nominees Limited ("Maunby") is interested in 23,671,710
ordinary shares of the Company, representing 8.8 per cent of the
issued share capital of the Company.
Maunby Nominees Limited controls the voting rights over
23,671,710 ordinary shares of the Company, which are held by
clients of Maunby Investment Management Ltd.
Of the 23,671,710 ordinary shares, 18,627,362 ordinary shares
are held by Nicholas Martel, a non-executive director of Byotrol
and client of Maunby. Mr Martel has a personal beneficial interest
in 2,100,000, representing 0.78 per cent of the Company's issued
share capital. Mr. Martel also has a non-beneficial interest in
16,527,362 ordinary equating to 6.17 per cent of the issued share
capital of Byotrol. Mr Martel's personal beneficial interest in
Byotrol ordinary shares remains unchanged.
Enquiries:
Byotrol plc 01925 742 000
David Traynor - Chief Executive
Dawn Marshall - Group Marketing
Controller
finnCap Ltd 020 7220 0500
(Nominated Adviser & Broker)
Geoff Nash/Carl Holmes/James
Thompson - Corporate Finance
Mia Gardner - Corporate Broking
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer
of residual antimicrobial technologies, maximising insights to
identify, develop, formulate and commercialise cutting-edge
antimicrobial technologies delivered in direct sales and in
long-term licensing partnerships with consumer and professional
multi-nationals.
Our patented suite of technologies deliver powerful
broad-spectrum efficacy with residual performance optimised against
commonly occurring and industry-specific pathogens.
For more information, please go to www.byotrol.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFMGMZKLZGVZM
(END) Dow Jones Newswires
February 19, 2016 10:34 ET (15:34 GMT)
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2024 a Ago 2024
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Ago 2023 a Ago 2024